MINERVA UROLOGICA E NEFROLOGICA, cilt.67, ss.187-196, 2015 (SCI İndekslerine Giren Dergi)
Aim. Objective of the present study was to investigate whether calcium antagonist use is associated with lower hemoglobin levels and/or higher erythropoiesis stimulating agent (ESA) requirement in hemodialysis patients.